Pulse News - The Hindu BusinessLine

SENSEX 78,398.31

+ 1,059.30

NIFTY 23,753.10

+ 299.30

CRUDEOIL 5,823.00

+ 4.00

GOLD 75,359.00

+ 312.00

SILVER 90,791.00

+ 278.00

SENSEX 78,398.31

+ 1,059.30

NIFTY 23,753.10

+ 299.30

NIFTY 23,753.10

+ 299.30

CRUDEOIL 5,823.00

+ 4.00

CRUDEOIL 5,823.00

+ 4.00

GOLD 75,359.00

+ 312.00

specials

Mihaela Rosu

Spotlight on ways to end violence against children

Concussion: FIFA kicks off ‘suspect and protect’ drive

Planned meals, personal trainer, and a tea for every reason

Why more NRIs are buying health insurance in India

Making medicines at the point of patient care

A ‘shadow ban’ in plain sight

Outgunning fake drugmakers

Morning runs, protein-packed breakfast, and a rest day

RISKS VS BENEFITS: Alzheimer’s drug Leqembi will be available to recommended patients through a controlled access programme

From the regulator. Limited use of Leqembi to treat early Alzheimer’s disease

After re-examining its initial opinion, the European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended granting marketing auth

By Team BL

NEW READING: India’s medical device market is expected to grow from $14 billion to $30 billion by 2030

Walking the fine line between making and importing medical devices

Scuba diving, decluttering, and switching off

Antimicrobial resistance awareness week

Measles: An avoidable surge

Today's Poll

Do you think gold prices will continue to decline?

Health coverage for India’s ‘missing middle’

Winter is coming

Toxic air chokes urban India

Navigating the flood of healthcare information, with a little help from AI

Sign into Unlock benefits!

Access 10 free stories per month
Access to comment on every story
Sign up/Manage to our newsletters
Get notified by email for early preview to new features, discounts & offers